new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)





Similar
Filing Names

Gruenenthal Gmbh
Gruenenthal Gmbh_20100107
  

Gruenenthal Gmbh patents

Recent patent applications related to Gruenenthal Gmbh. Gruenenthal Gmbh is listed as an Agent/Assignee. Note: Gruenenthal Gmbh may have other listings under different names/spellings. We're not affiliated with Gruenenthal Gmbh, we're just tracking patents.

ARCHIVE: New 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "G" | Gruenenthal Gmbh-related inventors




Date Gruenenthal Gmbh patents (updated weekly) - BOOKMARK this page
03/30/17Prolonged release pharmaceutical composition containing 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)phenol
03/23/17Titration of tapentadol
03/09/17Pharmaceutical composition comprising (1r,4r)-6'-fluoro-n,n-dimethyl-4-phenyl-4',9'-dihydro-3'h-spiro[cyclohexane-1,1'-pyrano[3,4,b]indo]-4-amine and antidepressants
03/02/17Device and formulation for topical treatment of pain affecting the vulvar area of the female human genital organ
02/16/17Treatment of irritable bowel syndrome
02/02/17Abuse-proofed dosage forms
12/15/16Pharmaceutical combination
12/15/16Pharmaceutical dosage forms comprising 6'-fluoro-(n-methyl- or n,n-dimethyl-)-4-phenyl-4',9'-dihydro-3'h-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine
12/15/16Abuse-proofed dosage form
12/15/16Process for the preparation of 5-fluorotryptophol
12/08/16Method of inhibiting chronification of pain
12/01/16Use of 1-phenyl-3-dimethylaminopropane compounds for treating rheumatoid pain
12/01/16Semisolid aqueous pharmaceutical composition containing tapentadol
09/29/16Stable formulation for parenteral administration of tapentadol
09/29/16Combination of selected analgesics and cox-ii inhibitors
09/22/16Spirocyclic cyclohexane compounds useful to treat substance dependency
09/08/16Process for preparing substituted 3-(1-amino-2-methylpentane-3-yl)phenyl compounds
08/04/16Aqueous pharmaceutical formulation of tapentadol for oral administration
07/14/16Pharmaceutical composition comprising (1r,4r)-6'-fluoro-n,n-dimethyl-4-phenyl-4',9'-dihydro-3'h-spiro[cyclohexane-1,1'-pyrano-[3,4,b]indol]-4-amine and a propionic acid derivative
07/07/16Pharmaceutical composition comprising (1r,4r)-6'-fluoro-n,n-dimethyl-4-phenyl-4',9'-dihydro-3'h-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine and a gabapentinoid
06/09/16Cis-tetrahydro-spiro(cyclohexane-1, 1' -pyrido[3,4-b]indole)-4-amine compounds
06/02/16Prolonged release pharmaceutical composition containing 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)phenol
05/12/16Pharmaceutical combination
05/05/16Crystalline forms of (-)-(1r,2r)-3-(3-dimethylamino-1-ethyl-2-methylpropyl)-phenol hydrochloride
04/21/16Parenteral administration of tapentadol
03/17/16Titration of tapentadol
02/18/16Pharmaceutical combination
02/18/16Pharmaceutical combination
01/21/16Substituted azaspiro(4.5)decane derivatives
12/31/15Crush resistant delayed-release dosage forms
12/03/15Mixed orl1/mu-agonists for the treatment of pain
11/12/15Process for preparing spirocyclic cyclohexane compounds, compositions containing such compounds and using such compounds
07/02/15Process for the production of an abuse-proofed solid dosage form
07/02/15Process for the production of an abuse-proofed solid dosage form
05/28/15Electric-field assisted administration of tapentadol
05/28/15Pharmaceutical patch for transdermal administration of tapentadol
04/23/15Pharmaceutical dosage forms comprising 6'-fluoro-(n-methyl- or n,n-dimethyl-)-4-phenyl-4',9'-dihydro-3'h-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine
04/09/15Substituted phenylureas and phenylamides as vanilloid receptor ligands
01/15/15Use of tapentadol for inhibiting and/or treating depression and anxiety
01/08/15Substituted phenylureas and phenylamides as vanilloid receptor ligands
09/25/14Crystalline cis-(e)-4-(3-fluorophenyl)-2',3',4',9'-tetrahydro-n,n-dimethyl-2'-(1-oxo-3-phenyl-2-propenyl)-spiro[cyclohexane-1,1'[1h]-pyrido[3,4-b]indol]-4-amine
08/28/14Tapentadol compositions
06/26/14Novel vanilloid receptor ligands and use thereof for the production of pharmaceutical preparations
06/19/14Abuse-proofed dosage form
05/22/14Substituted phenylureas and phenylamides as vanilloid receptor ligands
04/24/14Crush resistant delayed-release dosage forms
04/24/14Abuse-proofed oral dosage form
04/24/14Process for the production of an abuse-proofed solid dosage form
04/17/14Abuse-proofed dosage form
03/20/14Crush resistant delayed-release dosage forms
03/20/14Abuse-proofed dosage forms
03/20/14Abuse-proofed dosage forms
01/09/14Crystalline forms of (-)-(1r, 2r)-3-(3-dimethylamino-1-ethyl-2-methylpropyl)-phenol hydrochloride
12/19/13Process for preparing substituted 3-(1-amino-2-methylpentane-3-yl)phenyl compounds
11/28/13Pharmaceutical composition comprising (1r,4r)-6'-fluoro-n, n-dimethyl-4-phenyl-4,9' -dihydro-3'h-spiro[cyclohexane-1,1' -pyrano[3,4,b]indol]-4-amine and an anticonvulsant
11/28/13Pharmaceutical composition comprising (1r,4r)-6'-fluoro-n,n-dimethyl-4-phenyl-4',9'-dihydro-3'h-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine and a nsar
11/28/13Pharmaceutical composition comprising (1r,4r)-6'-fluoro-n,n-dimethyl-4-phenyl-4',9'-dihydro-3'h-spiro[cyclohexane-1,1'-pyrano-[3,4,b]indol]-4-amine and a salicylic acid component
11/21/13Pharmaceutical composition comprising (1r,4r)-6'-fluoro-n,n-dimethyl-4-phenyl-4',9'-dihydro-3'h-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine and antidepressants
11/21/13Pharmaceutical composition comprising (1r,4r)-6'-fluoro-n,n-dimethyl-4-phenyl-4'9'-dihydro-3'h-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine and a gabapentinoid
11/21/13Pharmaceutical composition comprising (1r,4r)-6'-fluoro-n, n-dimethyl-4-phenyl-4,9' -dihydro-3'h-spiro[cyclohexane-1,1' -pyrano[3,4,b]indol]-4-amine and paracetamol or propacetamol
09/26/13Pharmaceutical dosage form
09/19/13Hcl polymorphs of 3-((2-(dimethylamino)methyl(cyclohex-1-yl))phenol
09/12/13Prolonged release pharmaceutical composition containing 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)phenol
09/05/13Substituted spiro-amide compounds
09/05/13Crystalline (1r,4r)-6'-fluoro-n,n-dimethyl-4-phenyl-4',9'-dihydro-3'h-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine
Patent Packs
08/15/13Pharmaceutical patch for transdermal administration of (1r,4r)-6'-fluoro-n,n-dimethyl-4-phenyl-4',9'-dihydro-3'h-spiro[cyclohexane-1,1'-pyrano[3,4-b]indol]-4-amine
08/08/13(1r,4r)-6'-fluoro-(n-methyl- or n,n-dimethyl-)-4-phenyl-4',9'-dihydro-3'h-spiro-[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine for treating fibromyalgia and chronic fatigue syndrome
07/25/13Pharmaceutical combination
06/13/13Solid forms of (1r,4r)-6'-fluoro-n,n-dimethyl-4-phenyl-4',9'-dihydro-3' h-spiro-[cyclohexane-1,1'-pyrano-[3,4,b]indol]-4-amine hydrochloride
06/13/13Salts and polymorphs of dexrabeprazole
06/13/13Process for the preparation of (1r,4r)-6'-fluoro-(n,n-dimethyl- and n-methyl)-4-phenyl-4',9'-dihydro-3'h-spiro[cyclohexane-1,1'-pyrano-[3,4,b]indol]-4-amine
05/23/13Tamper-resistant oral pharmaceutical dosage form comprising opioid antagonist and/or aversive agent, polyalkylene oxide and anionic polymer
05/16/13Crystalline (1r, 4r)-6'-fluoro-n,n-dimethyl-4-phenyl-4',9'-dihydro-3'h-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine
05/09/13Treatment of irritable bowel syndrome
05/02/13Combination of selected analgesics and cox-ii inhibitors
04/04/13Intrathecal or epidural administration of 3-[(1s,2s)-3-(dimethylamino)-1-ethyl-2-methylpropyl]phenol
03/28/13Amine substituted methanesulfonamide derivatives as vanilloid receptor ligands
03/28/13Aryl or n-heteroaryl substituted methanesulfonamide derivatives as vanilloid receptor ligands
03/07/13Process for the dehydration of substituted 4-dimethylamino-2-aryl-butan-2-ol compounds and process for the preparation of substituted dimethyl-(3-aryl-butyl)- amine compounds by heterogeneous catalysis
01/31/13Substituted heterocyclic aza compounds
Patent Packs
01/31/13Substituted heteroaromatic pyrazole-containing carboxamide and urea compounds as vanilloid receptor ligands
01/31/13Substituted bicyclic aromatic carboxamide and urea compounds as vanilloid receptor ligands
01/24/13Aqueous pharmaceutical formulation of tapentadol for oral administration
01/10/13Crystalline (1r,4r)-6'-fluoro-n,n-dimethyl-4-phenyl-4',9'-dihydro-3'h-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine
12/06/12Treatment of pain associated with trigeminal neuralgia
12/06/12Method of inhibiting chronification of pain
11/29/12Vanilloid receptor ligand compounds, pharmaceutical compositions containing them, a producing them and the use thereof to treat pain and various other conditions
11/29/12Crystalline forms of (-)-(1r,2r)-3-(3-dimethylamino-1-ethyl-2-methylpropyl)-phenol hydrochloride
11/01/12Use of tapentadol for inhibiting and/or treating depression and anxiety
10/11/12Substituted phenylureas and phenylamides as vanilloid receptor ligands
10/04/12Abuse-proofed dosage form
10/04/12Ingestible insect repellent composition and system
09/06/12Semisolid aqueous pharmaceutical composition containing tapentadol
09/06/12Parenteral administration of tapentadol
07/12/12Salt of dimethylaminomethyl-phenyl-cyclohexane and crystalline forms thereof
06/14/12Method for synthesizing substituted aminocyclohexanone compounds
05/10/12Substituted bicyclic carboxamide and urea compounds as vanilloid receptor ligands
05/10/12Substituted heteroaromatic carboxamide and urea compounds as vanilloid receptor ligands
05/03/12Abuse-proofed dosage form
03/22/12Substituted benzamide compounds
03/08/12Substituted tetrahydropyrrolopyrazine compounds
02/23/12Substituted cyclic carboxamide and urea derivatives as ligands of the vanilloid receptor
02/16/123-(2-dimethlaminomethyl cyclohexyl)phenol retard formulation
02/16/12Tapentadol for treating pain due to osteoarthritis
02/09/12Abuse-proofed dosage form
02/09/12Pharmaceutical dosage forms comprising 6'-fluoro-(n-methyl- or n,n-dimethyl-)-4-phenyl-4',9'-dihydro-3'h-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine
02/09/12Prolonged release pharmaceutical composition containing 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)phenol
02/02/12Cis-tetrahydro-spiro(cyclohexane-1,1'-pyrido[3,4-b]indole)-4-amine compounds
01/26/12Salts or co-crystals of 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol
01/26/12Axomadol or a metabolite thereof for use in the treatment of irritable bowel syndrome
Social Network Patent Pack
01/19/12Combination of selected opioids with muscarine antagonists for treating urinary incontinence
01/05/12Tapentadol for use in the treatment of irritable bowel syndrome
12/29/11Process for preparing spirocyclic cyclohexane compounds, compositions containing such compounds and using such compounds
12/15/11Crystalline forms of (1rs,2rs,6rs)-6-dimethylaminomethyl-1-(3-methoxyphenyl)cyclohexane-1,3-diol hydrochloride
12/15/11Pharmaceutical combination
12/15/11Process for preparing substituted 3-(1-amino-2-methylpentane-3-yl)phenyl compounds
12/08/11Vanilloid receptor ligands, pharmaceutical compositions containing them, process for making them, and use thereof to treat pain and other conditions
12/01/11Crystalline forms of (-)-(1r,2r)-3-(3-dimethylamino-1-ethyl-2-methylpropyl)-phenol hydrochloride
12/01/11Process for the preparation of substituted 1-aminomethyl-2-phenyl-cyclohexane compounds
11/17/11Novel and potent tapentadol dosage forms
Patent Packs
10/27/111-phenyl-2-dimethylaminomethylcyclohexane compounds and therapies for depressive symptoms, pain and incontinence
10/20/11Reactor array for producing and analyzing products
10/13/11Crystalline salts and/or co-crystals of o-desmethyltramadol
10/13/11Hci polymorphs of 3-((2-(dimethylamino)methyl (cyclohex-1-yl))phenol
10/06/11Sample carrier and achieving comparable analytical results by aligning test substances on a uniform plane
09/15/11Substituted 1-oxa-2,8-diaza-spiro [4,5] dec-2-ene derivatives and related treatment methods
07/28/11Vanilloid receptor ligands, pharmaceutical compositions containing them, process for making them, and use thereof for treating pain and other conditions
03/10/11Crystalline modifications of 6-dimethylaminomethyl-1-(3-methoxyphenyl)-cyclohexane-1,3-diol
03/03/11Pharmaceutical combination comprising 6-dimethylaminomethyl-1-(3-methoxy-phenyl)-cyclohexane-1,3-diol or 6-dimethylaminomethyl-1-(3-hydroxy-phenyl)-cyclohexane-1,3-diol and an antiepileptic
03/03/11Spirocyclic cyclohexane compounds useful to treat substance dependency
02/24/11Salt of dimethylaminomethyl-phenyl-cyclohexane and crystalline forms thereof
01/20/11Pharmaceutical containing a horomone combination having a contraceptive effecr and an insulin sensitizer
01/13/11Substituted benzimidazoles, benzothiazoles and benzoxazoles
01/06/11Substituted aromatic carboxamide and urea derivatives as vanilloid receptor ligands
12/30/10Substituted phenylureas and phenylamides as vanilloid receptor ligands
12/30/10Use of axomadol for treatment of arthrosis pain
12/30/10Tapentadol for treating pain due to osteoarthritis
12/23/10Substituted sulfonamide compounds
12/16/10Antisense oligonucleotides against vr1
12/16/10Substituted sulfonamide compounds
12/09/10Use of 1-phenyl-3-dimethylamino-propane compounds for treating neuropathic pain
11/04/10Combination of selected analgesics and cox-ii inhibitors
11/04/10Method of inhibiting inflammatory pain
11/04/10Use of 1-phenyl-3-dimethylaminopropane compounds for treating rheumatoid pain
11/04/10Method of treating pain caused by inflammation
09/30/10Substituted spiro-amide compounds
09/30/10C-(2-phenyl-cyclohexyl)-methylamine compounds for the treatment of anxiety disorders
09/23/10Spirocyclic cyclohexane compounds
09/16/10Substituted spiroamide compounds
09/02/10Abuse-resistant pharmaceutical dosage form
Patent Packs
09/02/10Substituted indole compounds
08/05/10Pharmaceutical composition containing 6-dimethylaminomethyl-1-(3-methoxyphenyl)-cyclohexane-1,3-diol with delayed active ingredient release
07/29/10Pharmaceutical combination
07/08/10Substituted pyrimidine and triazine compounds
06/24/10Crystalline forms of (-)-(1r,2r)-3-(3-dimethylamino-1-ethyl-2-methylpropyl)-phenol hydrochloride
06/17/10Substituted disulfonamide compounds
05/06/10Substituted spiroamine compounds
04/29/10Substituted 4,5,6,7-tetrahydrothienopyridines as kcnq2/3 modulators
04/22/10Abuse-resistant dosage form
04/22/10Process for the preparation of (1r,2r)-3-(3-dimethylamino-1-ethyl-2-methylpropyl)-phenol
03/25/10Hcl polymorphs of 3-((2-(dimethylamino)methyl-(cyclohex-1-yl))phenol
03/18/10Coated pellets
03/18/10Pharmaceutical composition comprising 6-dimethylaminomethyl-1-(3-methoxy-phenyl)-cyclohexane-1,3-diol and paracetamol
03/11/10Pharmaceutical combination comprising 6-dimethylaminomethyl-1-(3-methoxy-phenyl)-cyclohexane-1.3-diol and an nsaid
03/11/10Pharmaceutical combination
02/25/10Spirocyclic cyclohexane compounds
02/25/10Spirocyclic cyclohexane compounds
01/07/10Substituted tetrahydropyrrolopyrazine compounds and the use thereof in the treatment and/or inhibition of pain
01/07/10C-(2-phenyl-cyclohexyl)-methylamine compounds for therapy of fibromyalgia
12/31/09Preparation of 3-[(1r,2r)-3-(dimethylamino)-1ethyl-2-methylpropyl]phenol
Social Network Patent Pack
12/03/09Substituted sulfonamide compounds
11/19/09Vr1 receptor ligands and u-opioid receptor ligands for the treatment of pain
11/19/09Substituted cyclohexylmethyl compounds
11/05/09Substituted sulfonamide compounds
11/05/09Substituted spiro-compounds and the use thereof for producing medicaments
10/22/09Substituted sulfonamide compounds
10/22/09Substituted sulfonamide compounds
10/15/09Substituted tetrahydropyrrolopyrazine compounds and the use thereof in pharmaceutical compositions
10/08/09Substituted sulfonamide compounds
10/08/09Process for producing (1rs,3rs,6rs)-6-dimethylaminomethyl-1-(3-methoxyphenyl)-cyclohexane-1,3-diol
09/17/09Crystalline modification of cefuroximaxetil
09/10/09Process for producing 6-dimethylaminomethyl-phenyl-cyclohexane-1,3-diols
08/27/09Use of 2,5-disubstituted thiazol-4-one derivatives in drugs
08/27/09Substituted benzo-condensed cycloheptanone derivatives and their use for producing drugs
08/13/09Substituted sulfonamide compounds
08/06/09Method of inhibiting polyneuropathic pain with 3-(2-dimethylaminomethylcyclohexyl) phenol
07/23/09Substituted sulfonamide compounds
07/23/09Substituted tetrahydroimidazopyridine compounds and the use thereof in the treatment of pain and other conditions
07/23/09Crystalline forms of (-)-(1r,2r)-3-(3-dimethylamino-1-ethyl-2-methylpropyl)-phenol hydrochloride
07/09/09Substituted 5,6,7,8-tetrahydro-pyrido[4,3-d]pyrimidine-2-yl compounds and 5,6,7,8-tetrahydro-quinazoline-2-yl compounds
Social Network Patent Pack
06/25/09Spirocyclic cyclohexane compounds
06/18/09Vanilloid receptor ligands, pharmaceutical compositions containing them, process for making them, and use thereof for treating pain and other conditions
06/11/09Crystalline modifications of (1r,2r)-3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol
05/28/09Method of measuring the activity of g(alpha)i-or g(alpha)o-coupled receptors using ca2+ influx in cells
05/28/091,3-disubstituted 4-methyl-1h-pyrrole-2-carboxamides and their use in medicaments
04/30/09Spirocyclic cyclohexane compounds with analgesic activity
04/23/09Substituted 1-oxa-3,8-diazaspiro[4.5]-decan-2-one-compounds and the use thereof for producing drugs
04/16/09Pharmaceutical combination
03/19/09Substituted 4,5,6,7 -tetrahydro-isoxazolo[4,5-c]pyridine compounds and use thereof for producing medicaments
03/19/09Substituted nicotinamide compounds and uses thereof
03/12/09Substituted 4-amino-quinazoline compounds with metabotropic glutamate receptor regulating activity and uses thereof
03/12/09Substituted oxazole compounds with analgesic activity
03/05/09Salts of substituted allophanates and their use in drugs
02/19/09Substituted imidazoline compounds
01/07/10C-(2-phenyl-cyclohexyl)-methylamine compounds for therapy of fibromyalgia







ARCHIVE: New 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Gruenenthal Gmbh in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Gruenenthal Gmbh with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';